Keep an eye on the most exciting biotech, medtech, and pharma startups that are disrupting the healthcare space. Learn about their innovations, funding rounds, and their potential to revolutionize the industry.
An In-Depth Analysis of the Most Promising Biotech Innovators Reshaping Healthcare The biotechnology landscape is experiencing a renaissance. As we approach 2026, a new generation
Healthcare markets exploded with deal-making activity as November opened with a bang. Novartis dropped $12 billion to acquire Avidity Biosciences, Novo Nordisk and Pfizer escalated
The healthcare sector delivered a remarkable week of innovation, deal-making, and regulatory transformation. From the FDA’s groundbreaking National Priority Review program to over $6.4 billion
Durham-based VC firm closes largest funding round amid sector downturn, marking 25 years and 100th portfolio investment Hatteras Venture Partners has closed two investment funds
Flow cytometry leader schedules presentations at three major healthcare investment conferences Cytek Biosciences announced its participation in three prominent investor conferences: the UBS Precision Medicine
Sector-wide fundraising activity reflects continued capital needs across biotech industry August 12 marked a particularly active day for biotech fundraising, with companies including 180 Life
Strategic Leaning in a Capital-Conscious Biotech Environment Flagship Pioneering’s Alltrna has made the unusual decision to trim its workforce ahead of dosing its first patient
Quick Summary Investment Amount: Agomab Therapeutics raised $89 million in Series D financing. Key Backers: Led by new investors Sanofi and Invus, with participation from
Resolution Therapeutics has secured $85 million in new funding to continue developing its macrophage-based therapies for liver diseases. The company is leveraging the natural regenerative
Biotechnology is advancing rapidly, driving innovation across healthcare, agriculture, food, and manufacturing. At the forefront of these advancements are gene editing technologies like CRISPR/Cas9, which
